Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Talkspace
TALK
Talkspace
Telehealth Momentum And AI Tools Will Transform Mental Care
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
22 Aug 25
Updated
22 Aug 25
1
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$6.00
53.3% undervalued
intrinsic discount
22 Aug
US$2.80
Loading
1Y
58.2%
7D
9.4%
Author's Valuation
US$6.0
53.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$6.0
53.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-82m
367m
2018
2020
2022
2024
2025
2026
2028
Revenue US$367.5m
Earnings US$53.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
16.88%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$53.41m
Earnings '28
x
22.29x
PE Ratio '28
=
US$1.19b
Market Cap '28
US$1.19b
Market Cap '28
/
163.17m
No. shares '28
=
US$7.30
Share Price '28
US$7.30
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$5.99
Fair Value '25